MALCOVA

Developing a game-changing #densebreastimaging device involves a lot of tough technical work, but the revelation of hidden inner structures is always a treat! The insides of a lumpy bumpy mini-pumpkin are spooky but beautiful imaged with our proprietary Narrow-Beam technology. Happy Halloween! ?#breastcancerawarenessmonth?#happyhalloween

Thrilled that the #NSF has highlighted our work at MALCOVA in honor of #BreastCancerAwareness month! https://lnkd.in/gtZWzBY5

The American Cancer Society recently reported a significant rise in breast cancer rates among younger women, particularly Asian American women under 50. This underscores the urgent need for improved early detection, especially in dense breast tissue. We are addressing this critical issue with MALCOVA's Breast Monarc technology, which is specifically designed to enhance early cancer detection and outcomes for this underserved group of patients.

We’re excited to announce that we’ve received an NIH SBIR Phase II clinical trial grant to advance our stand-alone breast cancer imaging solution using MALCOVA's Narrow-Beam CT technology. This innovation enables effective cancer detection in dense breast women, eliminating the need for compression, and directly addressing the inherent limitation of the current gold-standard breast imaging modality. This study is a collaboration with Yale University Radiology (Dr. John Lewin's group) and Stanford University Radiology (Dr. Adam Wang's research laboratory). #BreastCancerAwareness #MedicalInnovation #NIH

In the Spring of 2023, following more than a decade of effort from advocacy groups, the FDA announced that all women obtaining breast imaging with Mammography in the U.S. should be informed of their #breastdensity. Yesterday, September 10th, this mandate went into full effect. Since our founding, #MALCOVA has been dedicated to developing a comfortable, safe, and effective #breastcancerimaging technology for the nearly 50% of women who have #densebreasts . Increased awareness among women is a major step forward. We envision a future where women and their physicians are not just armed with information, but have the best device at hand to do something about it. -- Learn more: https://lnkd.in/eHH-4aWm https://lnkd.in/gnDbehhZ https://lnkd.in/eDzJHN-c

In the Spring of 2023, following more than a decade of effort from advocacy groups, the FDA announced that all women obtaining breast imaging with Mammography in the U.S. should be informed of their #breastdensity. Yesterday, September 10th, this mandate went into full effect. Since our founding, #MALCOVA has been dedicated to developing a comfortable, safe, and effective #breastcancerimaging technology for the nearly 50% of women who have #densebreasts . Increased awareness among women is a major step forward. We envision a future where women and their physicians are not just armed with information, but have the best device at hand to do something about it. -- Learn more: https://lnkd.in/eHH-4aWm https://lnkd.in/gnDbehhZ https://lnkd.in/eDzJHN-c

It was an incredibly fruitful summer at MALCOVA. Special thanks to our phenomenal interns Anishka Bhartiya and Kira Funk for being part of it! We wish them both the best on their continued educational journeys at #JohnsHopkinsUniversity and #UofWisconsinMadison.

What a delightful visit to Columbus it was last week to take part in the ACA Summit! We're so honored to have been able to share our efforts and our vision, and to have MALCOVA deemed WINNER of the "Venture Bucks" competition!!!????

Cheers to Erik Chell and the fantastic team at Triple Ring Technologies for planting seeds of inspiration in the next generation of brilliant STEM minds in the making!